Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Update Il y a 5 ans
Reference: NCT01605708

Woman and Man

Extract

The purpose of this study is to assess the clinical activity on refractory moderate-to-severe pruritus of a single intravenous (IV) dose of REGN846 in adult patients with moderate-to-severe atopic dermatitis (AD).


Inclusion criteria

  • Pruritus ,Atopic dermatitis

Links